相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs
Edoardo Conticini et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Are my patients with rheumatic diseases at higher risk of COVID-19?
Gabriel Figueroa-Parra et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Sara Monti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'
Kristin M. D'Silva et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Erica J. Brenner et al.
GASTROENTEROLOGY (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York
Rebecca Haberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases
Jose L. Pablos et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
Qing Ye et al.
JOURNAL OF INFECTION (2020)
STEROID IS FIRST DRUG SHOWN TO PREVENT DEATHS FROM COVID-19
Heidi Ledford
NATURE (2020)
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
Xabier Michelena et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
分享论文
